Geron Q4 2025 Earnings Preview
Source: SeekingAlpha
2026-02-24 10:09:43 ET
More on Geron
- Geron: Underpromise And Overdeliver Could Be The 2026 Strategy (Rating Upgrade)
- Geron: From Launch Hype To Later-Line Gravity
- Geron Corporation: Can Restructuring Bring The Stock Back To Life? I'm On The Sidelines
- Geron forecasts top-line growth, lower operating spend for 2026
- Geron strategic restructuring plan focuses on Rytelo growth
Read the full article on Seeking Alpha
For further details see:
Geron Q4 2025 Earnings Preview
Geron Corporation
NASDAQ: GERN
GERN Trading
6.58% G/L:
$1.70 Last:
6,081,158 Volume:
$1.59 Open:
GERN Latest News
February 25, 2026 07:00:00 am
Geron Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
GERN Stock Data
$1,030,943,769
590,989,314
0.47%
88
N/A
Biotechnology & Life Sciences
Healthcare
US
FOSTER CITY
